These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30152571)
1. Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice. Bonham CA; Rodrigues M; Galvez M; Trotsyuk A; Stern-Buchbinder Z; Inayathullah M; Rajadas J; Gurtner GC Wound Repair Regen; 2018 May; 26(3):300-305. PubMed ID: 30152571 [TBL] [Abstract][Full Text] [Related]
2. Transdermal deferoxamine prevents pressure-induced diabetic ulcers. Duscher D; Neofytou E; Wong VW; Maan ZN; Rennert RC; Inayathullah M; Januszyk M; Rodrigues M; Malkovskiy AV; Whitmore AJ; Walmsley GG; Galvez MG; Whittam AJ; Brownlee M; Rajadas J; Gurtner GC Proc Natl Acad Sci U S A; 2015 Jan; 112(1):94-9. PubMed ID: 25535360 [TBL] [Abstract][Full Text] [Related]
3. Optimization of transdermal deferoxamine leads to enhanced efficacy in healing skin wounds. Duscher D; Trotsyuk AA; Maan ZN; Kwon SH; Rodrigues M; Engel K; Stern-Buchbinder ZA; Bonham CA; Barrera J; Whittam AJ; Hu MS; Inayathullah M; Rajadas J; Gurtner GC J Control Release; 2019 Aug; 308():232-239. PubMed ID: 31299261 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis. Gao SQ; Chang C; Li JJ; Li Y; Niu XQ; Zhang DP; Li LJ; Gao JQ Drug Deliv; 2018 Nov; 25(1):1779-1789. PubMed ID: 30338719 [TBL] [Abstract][Full Text] [Related]
5. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α. Hou Z; Nie C; Si Z; Ma Y Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275 [TBL] [Abstract][Full Text] [Related]
6. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis. Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768 [TBL] [Abstract][Full Text] [Related]
7. Deferoxamine enhances the regenerative potential of diabetic Adipose Derived Stem Cells. Hopfner U; Maan ZN; Hu MS; Aitzetmüller MM; Zaussinger M; Kirsch M; Machens HG; Duscher D J Plast Reconstr Aesthet Surg; 2020 Sep; 73(9):1738-1746. PubMed ID: 32418841 [TBL] [Abstract][Full Text] [Related]
8. Deferoxamine: An Angiogenic and Antioxidant Molecule for Tissue Regeneration. Holden P; Nair LS Tissue Eng Part B Rev; 2019 Dec; 25(6):461-470. PubMed ID: 31184273 [TBL] [Abstract][Full Text] [Related]
9. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats. Mehrabani M; Najafi M; Kamarul T; Mansouri K; Iranpour M; Nematollahi MH; Ghazi-Khansari M; Sharifi AM Cell Prolif; 2015 Oct; 48(5):532-49. PubMed ID: 26332145 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing. Duscher D; Januszyk M; Maan ZN; Whittam AJ; Hu MS; Walmsley GG; Dong Y; Khong SM; Longaker MT; Gurtner GC Plast Reconstr Surg; 2017 Mar; 139(3):695e-706e. PubMed ID: 28234841 [TBL] [Abstract][Full Text] [Related]
11. Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression. Wang C; Cai Y; Zhang Y; Xiong Z; Li G; Cui L PLoS One; 2014; 9(6):e100818. PubMed ID: 24963878 [TBL] [Abstract][Full Text] [Related]
12. The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads. Li J; Fan L; Yu Z; Dang X; Wang K Exp Biol Med (Maywood); 2015 Feb; 240(2):273-80. PubMed ID: 25294892 [TBL] [Abstract][Full Text] [Related]
13. Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing. Kong L; Wu Z; Zhao H; Cui H; Shen J; Chang J; Li H; He Y ACS Appl Mater Interfaces; 2018 Sep; 10(36):30103-30114. PubMed ID: 30113159 [TBL] [Abstract][Full Text] [Related]